When:
Tuesday, Mar 14, 2017 9:00a -
Thursday, Mar 16, 2017 4:15p

Where:
Sheraton Boston Hotel
39 Dalton Street
Boston, MA 02199

EventScheduled OfflineEventAttendanceMode

Admission:
$Gold - conference and 2 workshops: USD 3897, Silver - conferenece and 1 workshop: USD 3298, Bronze - conference only : USD 2699, Workshop: USD 699

Categories:
Lectures & Conferences

Event website:
https://go.evvnt.com/77566-4

Over 1000 clinical trials involving ICIs are currently underway


New ICI combination trials are registered at an average rate of one every 1.4 days


Are you doing enough to keep pace with the rapidly evolving immuno-oncology space?


Focussed exclusively on immune checkpoint inhibitors, ICI Boston 2017 will provide you with an in-depth insight into the preclinical, translational and clinical challenges that drug developers face in progressing checkpoint inhibitors onto the market.


Rather than simply presenting PD-1 success stories, ICI Boston will drill down into the drug development challenges preventing immune checkpoint inhibitors from realizing their full potential. It will provide you with a sound biological understanding new targets and impacts on drug development.


ICI Boston will enable you to:


Gain insights into immuno-oncology combinations that deliver robust and durable patient responses
What does the biomarker story look like beyond PD-L1? Learn about novel patient stratification methods that take a more holistic view of the immune response
Appreciate the commercial strategy of the most advanced players and assess market opportunities for the year to come
Debate clinical strategies that support the rapid generation of trial data and support appropriate registrational paths
Assess novel preclinical models that effectively recapitulate the human immune system and improve predictability into the clinic
Understand how the tumor microenvironment can enhance immune responses and how you can broaden the therapeutic scope of treatments most effectively


Join us in Boston and acquire the knowledge you need to define your next 12 months of development strategy.


URLs:


Inquiries: https://go.evvnt.com/77566-0
Booking: https://go.evvnt.com/77566-1
Tickets: https://go.evvnt.com/77566-2
Twitter: https://go.evvnt.com/77566-3
Brochure: https://go.evvnt.com/77566-5


Speakers: Xiaosong Zhang, Barbara Joyce-Shaikh, Alison O’Mahony, David Kaufman, Marie Kosco-Vilbois, Geoff Gibney, Viviana Cremasco, Moitreyee Chatterjee-Kishore, Pedro Beltran, Scott Woodman, Jennifer Brogdon, Amy Beebe, Beth Trehu, David Tuck, Prasad Adusumilli, Frédéric Triebel, Kurt Schalper, Kris Sachsenmeier, Karsten Sauer, David Schaer, Jon Wigginton, Carl Morrison, Angie Park, Kuldeep Neote, Michael Postow, Francis Lee, Jannie Borst, Andrew Zloza, Sarah McWhirter, Zhen Su

Share this event

Add to:

Reddit
03/14/2017 09:00:00 03/16/2017 16:15:00 America/New_York ICI Boston Over 1000 clinical trials involving ICIs are currently underway New ICI combination trials are registered at an average rate of one every 1.4 days Are you doing enough to keep pace with the r... Sheraton Boston Hotel, Boston, MA 02199 false MM/DD/YYYY

Sponsored events